ストックスクリーナーアプリを入手
2.78
7.02%
-0.21
アフターアワーズ：
2.81
0.03
+1.08%
前日終値:
$2.99
開ける：
$2.84
24時間の取引高:
8.51M
Relative Volume:
2.30
時価総額：
$632.12M
収益：
-
当期純損益:
$-179.82M
株価収益率:
-2.0902
EPS:
-1.33
ネットキャッシュフロー:
$-159.16M
1週間 パフォーマンス:
-9.74%
1か月 パフォーマンス:
+17.80%
6か月 パフォーマンス:
+117.19%
1年 パフォーマンス:
+182.81%
1日の値動き範囲:
$2.7311
$2.875
1週間の範囲:
$2.7311
$3.21
52週間の値動き範囲:
$0.6617
$3.60
Gossamer Bio Inc Stock (GOSS) Company Profile
GOSS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GOSS
Gossamer Bio Inc
|
2.78 | 679.87M | 0 | -179.82M | -159.16M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Gossamer Bio Inc Stock (GOSS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-10 | アップグレード | UBS | Neutral → Buy |
| 2025-07-14 | 開始されました | Scotiabank | Sector Outperform |
| 2024-06-25 | 開始されました | Oppenheimer | Outperform |
| 2024-04-05 | 再開されました | Wedbush | Outperform |
| 2023-07-27 | ダウングレード | UBS | Buy → Neutral |
| 2023-03-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-03-01 | 開始されました | Guggenheim | Neutral |
| 2022-12-07 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2022-12-07 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2022-12-07 | ダウングレード | SMBC Nikko | Outperform → Neutral |
| 2022-10-20 | 開始されました | Goldman | Buy |
| 2022-09-21 | 開始されました | JP Morgan | Neutral |
| 2022-09-19 | 開始されました | Wedbush | Outperform |
| 2022-04-18 | 開始されました | Raymond James | Outperform |
| 2022-04-06 | 開始されました | UBS | Buy |
| 2022-01-10 | アップグレード | SMBC Nikko | Neutral → Outperform |
| 2021-11-09 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-09-21 | 再開されました | Piper Sandler | Overweight |
| 2020-06-29 | 開始されました | H.C. Wainwright | Buy |
| 2020-04-22 | 開始されました | Piper Sandler | Overweight |
| 2020-02-27 | 開始されました | Barclays | Overweight |
| 2019-12-03 | 再開されました | BofA/Merrill | Buy |
| 2019-10-30 | 開始されました | Berenberg | Buy |
| 2019-03-05 | 開始されました | Barclays | Overweight |
| 2019-03-05 | 開始されました | BofA/Merrill | Buy |
| 2019-03-05 | 開始されました | Evercore ISI | Outperform |
| 2019-03-05 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Gossamer Bio Inc (GOSS) 最新ニュース
Latham Watkins Advises Gossamer Bio in Option Agreement to Acquire Respira Therapeutics - Latham & Watkins LLP
Gossamer Bio Enters Merger Agreement with Respira - TipRanks
Gossamer Bio grants merger option and issues shares in Respira Therapeutics deal - Investing.com
Gossamer Bio (GOSS) Secures Option Agreement to Acquire Respira Therapeutics - GuruFocus
Gossamer Bio (GOSS) Secures Acquisition Option for Respira's Pro - GuruFocus
Respira therapeutics says enters into agreement granting Gossamer option to acquire co from Samsara BioCapital - MarketScreener
Gossamer Bio secures option to acquire Respira Therapeutics - Investing.com
Gossamer Bio secures option to acquire Respira Therapeutics By Investing.com - Investing.com Australia
First-Ever PRN Treatment for Pulmonary Hypertension: Gossamer Bio Eyes Acquisition of Breakthrough Drug RT234 - Stock Titan
Gossamer Bio Enters into Option Agreement to Acquire Respira Therapeutics and Its Lead Candidate, RT234, an Inhaled, On‑Demand Vardenafil for Pulmonary Hypertension - The Joplin Globe
First-Ever On-Demand Treatment for Pulmonary Hypertension: Gossamer Bio Eyes Breakthrough Inhaled Therapy - Stock Titan
How institutional ownership impacts Gossamer Bio Inc. stockMarket Sentiment Report & High Accuracy Swing Trade Signals - newser.com
Gossamer Bio, Inc. (GOSS) Stock Jumps 18% on FDA Updates and Seralutinib Progress - Yahoo Finance
Gossamer Bio, Inc.'s (NASDAQ:GOSS) Shares Climb 30% But Its Business Is Yet to Catch Up - 富途牛牛
Historical volatility pattern of Gossamer Bio Inc. visualizedPortfolio Performance Report & Long-Term Investment Growth Plans - newser.com
Smart tools for monitoring Gossamer Bio Inc.’s price actionJuly 2025 Selloffs & Real-Time Volume Analysis - newser.com
What’s next for Gossamer Bio Inc. stock price2025 Institutional Moves & Weekly Breakout Watchlists - newser.com
Gossamer Bio, Inc. Announces Presentations At the European Respiratory Society Congress 2025 - MarketScreener
Gossamer Bio Announces Presentations at the European Respiratory Society (ERS) Congress 2025 - The Joplin Globe
Gossamer Bio (NASDAQ:GOSS) Shares Gap UpHere's What Happened - MarketBeat
Can volume confirm reversal in Gossamer Bio Inc.Quarterly Profit Report & Technical Entry and Exit Tips - newser.com
Gossamer Bio (NASDAQ:GOSS) Lowered to Sell Rating by Wall Street Zen - MarketBeat
What indicators show strength in Gossamer Bio Inc.Day Trade & Free Verified High Yield Trade Plans - newser.com
Top chart patterns to watch in Gossamer Bio Inc.Trade Risk Assessment & Daily Volume Surge Signals - newser.com
Surprises Report: Is Gossamer Bio Inc stock heavily shortedRate Hike & Capital Efficiency Focused Strategies - خودرو بانک
Patterns Watch: How cyclical is Gossamer Bio Inc.’s revenue streamWeekly Gains Summary & Fast Entry and Exit Trade Plans - خودرو بانک
Real time breakdown of Gossamer Bio Inc. stock performanceQuarterly Portfolio Review & Entry Point Confirmation Signals - newser.com
Gossamer Bio (NASDAQ:GOSS) Stock Price Down 5%Time to Sell? - MarketBeat
Ideas Watch: How liquid is Gossamer Bio Inc. stockTrade Volume Summary & High Yield Stock Recommendations - khodrobank.com
What is AleAnna Inc.’s valuation compared to sectorJuly 2025 Decliners & Fast Moving Stock Watchlists - خودرو بانک
Gossamer Bio Inc. stock trendline breakdownTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Aug Retail: Does Gossamer Bio Inc. have a sustainable dividendTrade Ideas & Daily Growth Stock Tips - khodrobank.com
Aug Analyst Calls: How cyclical is Gossamer Bio Incs revenue streamJuly 2025 Chart Watch & Verified Momentum Stock Watchlist - خودرو بانک
Acadian Asset Management LLC Buys 1,253,353 Shares of Gossamer Bio, Inc. $GOSS - MarketBeat
What technical models suggest about Gossamer Bio Inc.’s comebackEarnings Recap Summary & Real-Time Volume Analysis Alerts - newser.com
Investor Mood: What is the long term forecast for Gossamer Bio Inc stockEarnings Trend Report & Weekly High Potential Alerts - khodrobank.com
Gossamer Bio Inc. stock trend outlook and recovery pathWeekly Profit Analysis & Long-Term Safe Investment Plans - newser.com
Gossamer Bio (NASDAQ:GOSS) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Evaluating Gossamer Bio Inc. with trendline analysisJuly 2025 Technicals & Community Supported Trade Ideas - newser.com
Pullback Watch: Should value investors consider Inspira Technologies Oxy BHN Ltd Equity WarrantOptions Play & Weekly High Conviction Trade Ideas - khodrobank.com
Aug Wrap: Is Gossamer Bio Inc in a long term uptrendWeekly Investment Recap & Real-Time Buy Signal Alerts - khodrobank.com
What candlestick patterns are forming on Gossamer Bio Inc.2025 Price Targets & Expert Curated Trade Setup Alerts - newser.com
Rally Mode: Does Gossamer Bio Inc stock benefit from AI growthJuly 2025 Closing Moves & Trade Opportunity Analysis - خودرو بانک
Using Bollinger Bands to evaluate Gossamer Bio Inc.2025 Breakouts & Breakdowns & Safe Entry Zone Tips - newser.com
Relative strength of Gossamer Bio Inc. in sector analysisJuly 2025 Closing Moves & AI Forecasted Stock Moves - newser.com
How to build a dashboard for Gossamer Bio Inc. stockWeekly Volume Report & Free Community Consensus Stock Picks - newser.com
H.C. Wainwright and Leerink Partners Reiterate ‘Buy’ Ratings on Gossamer Bio, Inc. (GOSS) - MSN
Siren L.L.C. Reduces Holdings in Gossamer Bio, Inc. $GOSS - MarketBeat
Treasury Yields: Is Gossamer Bio Inc in a long term uptrendJuly 2025 Highlights & Real-Time Volume Surge Alerts - خودرو بانک
US Market Recap: Is Gossamer Bio Inc. stock a smart retirement pickEarnings Overview Report & Stepwise Swing Trade Plans - خودرو بانک
Dip Buying: What is the long term forecast for Gossamer Bio Inc stockJuly 2025 Levels & Risk Controlled Swing Alerts - خودرو بانک
Gossamer Bio Inc (GOSS) 財務データ
収益
当期純利益
現金流量
EPS
2.43%
大文字化:
|
ボリューム (24 時間):